Ahead of his session at CPHI Barcelona, Lawrence De Belder, continuous manufacturing practice head at Pharmatech Associates, answers some questions on the transformative impact of CM on the pharmaceutical industry

Why does batch processes have quality traps? Why will CM be the next generation on quality?